The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Open accessAbstract
OBJECTIVE: To review pharmacologic and nonpharmacologic strategies for treating sleep disturbances in children and adolescents with autism spectrum disorder (ASD) and to develop recommendations for addressing sleep disturbance in this population. METHODS: The guideline panel followed the American Academy of Neurology 2011 guideline development process, as amended. The systematic review included studies through December 2017. Recommendations were based on evidence, related evidence, principles of care, and inferences. MAJOR RECOMMENDATIONS LEVEL B: For children and adolescents with ASD and sleep disturbance, clinicians should assess for medications and coexisting conditions that could contribute to the sleep disturbance and should address identified issues. Clinicians should counsel parents regarding strategies for improved sleep habits with behavioral strategies as a first-line treatment approach for sleep disturbance either alone or in combination with pharmacologic or nutraceutical approaches. Clinicians should offer melatonin if behavioral strategies have not been helpful and contributing coexisting conditions and use of concomitant medications have been addressed, starting with a low dose. Clinicians should recommend using pharmaceutical-grade melatonin if available. Clinicians should counsel children, adolescents, and parents regarding potential adverse effects of melatonin use and the lack of long-term safety data. Clinicians should counsel that there is currently no evidence to support the routine use of weighted blankets or specialized mattress technology for improving disrupted sleep. If asked about weighted blankets, clinicians should counsel that the trial reported no serious adverse events with blanket use and that blankets could be a reasonable nonpharmacologic approach for some individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“clinicians may recommend the use of melatonin which is usually well tolerated and has a low incidence of side effects [59].”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Owens, J. A., Spirito, A., & McGuinn, M. (2000) · Sleep · doi:10.1093/sleep/23.8.1d · Cited by 2,535
Self-citationShort- and long-term health consequences of sleep disruption
Medic, G., Wille, M., & Hemels, M. (2017) · Nature and Science of Sleep · doi:10.2147/nss.s134864 · Cited by 1,776
(1985) · PubMed · Cited by 1,427
Impact of Delaying School Start Time on Adolescent Sleep, Mood, and Behavior
Owens, J. A., Belon, K., & Moss, P. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.96 · Cited by 430
Self-citationSleep problems as possible predictors of intensified symptoms of autism*1
Schreck, K. A. (2003) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2003.04.007 · Cited by 419
The relationship between sleep and behavior in autism spectrum disorder (ASD): a review
Cohen, S., Conduit, R., Lockley, S. W., Rajaratnam, S. M., & Cornish, K. M. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-44 · Cited by 389
Adolescents, substance abuse, and the treatment of insomnia and daytime sleepiness
Bootzin, R. R., & Stevens, S. J. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.04.007 · Cited by 363 · cited 1×
“22,23 These interventions are short-term, multicomponent, goal-oriented psychotherapeutic treatments aiming to modify thinking patterns and behaviors that perpetuate insomnia (e.g., irregular sleep – wake schedules, poor sleep hygiene, and maladaptive habits).”
BackgroundSleep problems in autism: prevalence, cause, and intervention
Richdale, A. L. (1999) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162299000122 · Cited by 345
Experimental Restriction of Sleep Opportunity in Children: Effects on Teacher Ratings
Fallone, G., Acebo, C., Seifer, R., & Carskadon, M. A. (2005) · SLEEP · doi:10.1093/sleep/28.12.1561 · Cited by 325
Flagged first, then by citations
Research works printed but not linked: 3
- American Academy of Sleep Medicine. Case Book of Sleep Medicine, 2nd ed. Darien, IL: American Academy of Sleep Medicine; 2015.
- American Academy of Neurology. Clinical Practice Guideline Process Manual. St. Paul, MN: American Academy of Neurology; 2011.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). Washington, DC: American Psychiatric Publishing; 2000.
Cited by
Sorted by citations
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01183-1 · Cited by 233
Autism Spectrum Disorder and Sleep
Johnson, K., & Zarrinnegar, P. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2020.08.012 · Cited by 87
Melatonin: Facts, Extrapolations and Clinical Trials
Boutin, J. A., Kennaway, D. J., & Jockers, R. (2023) · Biomolecules · doi:10.3390/biom13060943 · Cited by 83
Neurodevelopmental Disorders Commonly Presenting with Sleep Disturbances
Shelton, A. R., & Malow, B. A. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00982-8 · Cited by 84
Mental health challenges faced by autistic people
Lai, M. (2023) · Nature Human Behaviour · doi:10.1038/s41562-023-01718-2 · Cited by 88
Metadata
- Authors
- Williams Buckley, A., Hirtz, D., Oskoui, M., Armstrong, M. J., Batra, A., Bridgemohan, C., Coury, D., Dawson, G., Donley, D., Findling, R. L., Gaughan, T., Gloss, D., Gronseth, G., Kessler, R., Merillat, S., Michelson, D., Owens, J., Pringsheim, T., Sikich, L., Stahmer, A., Thurm, A., Tuchman, R., Warren, Z., Wetherby, A., Wiznitzer, M., & Ashwal, S.
- Affiliations
- From the Pediatrics and Developmental Neuroscience Branch (A.W.B., T.G., R.K., A.T.), National Institute of Mental Health, NIH, Bethesda, MD; Department of Neurological Sciences (D.H.), University of Vermont Medical Center, Burlington; Department of Pediatric Neurology (M.O.), McGill University Health Centre, Montréal, Canada; Department of Neurology (M.J.A.), University of Florida College of Medicine, Gainesville; Developmental Pediatrics (A.B.), Our Special Kids Pediatric Care, Los Angeles, CA;...
- University of Vermont (US)
- ORCID
- Venue
- Neurology
- Published
- 2020-03-03
- Volume
- 94
- Issue
- 9
- Pages
- 392-404
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC7238942
- OpenAlex
- W3006087000
- Cited by
- 228
- References
- 50
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 47 · 2023: 33 · 2022: 38 · 2021: 24 · 2020: 18
- FWCI
- 27.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD093074)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- autism spectrum disorder, insomnia, sleep disorders, children and adolescents, melatonin, behavioral sleep interventions, sleep hygiene, weighted blankets, nutraceuticals, pharmacotherapy
- MeSH terms
- Autism Spectrum Disorder, Adolescent, Child, Humans, Sleep Initiation and Maintenance Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
